中文 | ENG

第57卷 第6期 2024-11
Emerging robot-guided techniques in endodontic microsurgery

.........................

第57卷 第6期 2024-11
Management of subcapsular hematoma after living donor liver transplant

.........................

第57卷 第6期 2024-11
Urethral pseudodiverticulum with left-sided nonfunctioning kidney: Case report

.........................

第57卷 第6期 2024-11
Strategy to minimize surgical defect of dermatofi brosarcoma protuberans

.........................

第57卷 第6期 2024-11
Rapunzel syndrome—An uncommon disease with varied common presentations

.........................

第57卷 第6期 2024-11
Minimally invasive approaches to management of acute necrotizing pancreatitis

.........................

第57卷 第6期 2024-11
Innovative surgical technique: Addressing ethical concerns

.........................

第57卷 第6期 2024-11
Emergency surgery and HIV screening, clinical or universal scenarios?

.........................

第57卷 第6期 2024-11
High mortality rates associated with parainfl uenza virus, not metapneumovirus, infections in lung transplant recipients: A retrospective observation

.........................

第57卷 第6期 2024-11
Predatory clinical surgery journal, rescinding the decision to accept submitted article and unjustifi ed rejection and unprofessional conduct

.........................

第57卷 第6期 2024-11
Sacrifi cial of unilateral vertebral artery for fragment removal following vertebral artery injury by air rif le pellet gunshot: A case report

.........................

第57卷 第6期 2024-11
Evaluation of three-dimensional reconstruction technology in precision hepatectomy for primary liver cancer

.........................

第57卷 第6期 2024-11
Exploring the seasonal variation of anorectal disease: A comprehensive study

.........................

第57卷 第6期 2024-11
Efficacy of the minimal-invasive vacuum-assisted biopsy under direct visualization with ultrasound for impalpable breast lesions in Taiwanese female: A retrospective case-control study

.........................

第57卷 第6期 2024-11
Computed tomography on the 5th postoperative day helps distinguish grade C from grade B pancreatic fi stula after pancreaticoduodenectomy for periampullary cancer

.........................

第57卷 第6期 2024-11
Pressurized intraperitoneal aerosol chemotherapy (PIPAC): Why it will transform cancer surgery

.........................

第57卷 第5期 2024-9
Evaluating the pros and cons of anonymous commenting on PubPeer

.........................

第57卷 第5期 2024-9
Infected urachal cyst with urethral stricture disease presenting with intraperitoneal perforation of cyst and pyoperitoneum

.........................

第57卷 第5期 2024-9
COVID-19 vaccination and acute cholecystitis: A rare but important clinical problem

.........................

第57卷 第5期 2024-9
Hobnail-shaped primary prostatic urethral calculus due to urethral stricture disease

.........................
登入帳號才能閱讀全文
 
篇名 A retrospective study of postoperative chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
作者 Hui-Ling Yeh, Chung-Ping Hsu, Jin-Ching Lin, Jian-Sheng Jan,Jai-Fu Lin, Chen-Fa Chang
卷期/出版年月 45卷6期 (2012/12)
頁次 172-177
摘要 Objective: To investigate the role of postoperative chemoradiotherapy in locally advanced esophageal cancer after primary surgery. Methods: Forty-one patients with locally advanced esophageal cancer (30/41 pathologic Stage IIIA-C, 73.2%) who underwent radical surgery and complete postoperative chemoradiotherapy between May 2004 and May 2010 were enrolled. The radiotherapy was delivered by the intensity-modulated radiotherapy technique. Concurrently, chemotherapy with cisplatin and 5-fluorouracil was given on the 1st week and the 5th week of radiotherapy. The overall survival, disease-free survival, and local recurrence rate were calculated to determine the role of postoperative radiotherapy in locally advanced esophageal cancer. Univariate analysis was used to elucidate the prognostic risk factors. Results: After a median follow-up of 34.5 months (range, 3-87 months), the median overall survival was 13 months. The 1-year and 3-year overall survival rates were 61.0 % and 24.6%, respectively. The disease free survival after 1 year and 3 year was 42.8% and 28.1%, respectively. There was a significant difference in survival between the patients who had N0/1 and N2/3 disease by univariate analysis with 1-year survival and median survival rates of 66.7% versus 37.5% and 17 months versus 10.5 months, respectively (pZ0.036). The local recurrence rate was 17.1 % (7/41) at 3 years. Acute treatment-related toxicities were mild. Most of the patients died of distant metastasis. Conclusion: Postoperative chemoradiotherapy showed a mild acute treatment-related toxicity and a relatively good local control but these effects did not contribute a higher survival rate to patients with advanced esophageal cancer.
關鍵詞 esophageal cancer;postoperative chemoradiotherapy
分類 Original article

台灣外科醫學會雜誌 © 2006 Taiwan Surgical Association All Rights Reserved
會 址:台北市南京東路五段 31 號 3 樓
電 話:(02) 2769-7845 傳 真:(02) 2746-7149 Email: journal@surgery.org.tw